| May 24th, 2007, Thursday |
| HALL A |
|
| 08:30-10:30 |
Acute Myeloblastic Leukemia
Chairs: John Kersey, Ali Ünal
Recent Advances in the Biology of AML
John Kersey, USA
Chemotherapy in AML
Peter H. Wiernik, USA
Autologous Stem Cell Transplantation in AML
Norbert Claude Gorin, France
Allogeneic Stem Cell Transplantation in AML
Francesco Frassoni, Italy
SCIENTIFIC SUBCOMMITTEE MEETING |
| 10:00-12:30 |
Myeloma Scientific Subcommittee Meeting |
| 10:30-10:45 |
Break |
| HALL A |
|
| 10:45-12:15 |
Acute Lymphoblastic Leukemia
Chairs: Oliver Ottman, İsmet Aydoğdu
Ph+ ALL
Oliver Ottman, Germany
Treatment of Adult ALL
Charles Linker, USA
Treatment of Pediatric ALL
Giorgio Dini, Italy |
| 12:15-13:15 |
Lunch |
| HALL B |
|
| 13:15-14:15 |
Satellite Symposia, Janssen Cilag
Optimizing treatment strategies in Multiple Myeloma
Chair: Levent Ündar, Turkey
New Agents in Front Line Multiple Myeloma
Jean Luc Harousseau, France
Targeted Therapy and Tailored Treatment with Proteasome Inhibition in Multiple Myeloma
Orhan Sezer, Germany
Maximizing the Benefits of Bortezomib at First Relaps Multiple Myeloma
Ali Ünal, Turkey |
| 14:15-14:30 |
Break |
| HALL B |
|
| 14:30-15:30 |
Satellite Symposia, Bristol Myers Squibb
New developments for patients with resistant Ph+ CML and Ph+ ALL
Chair: Osman İlhan, Turkey
The role of new TKIs in imatinib resistant patients and imatinib intolerant patients
Jane Apperley, UK
Optimizing treatment decisions in treating Ph+ ALL
Zafer Gülbaş, Turkey |
| 15:30-15:45 |
Break |
| |
SCIENTIFIC SUBCOMMITTEE MEETING |
| 15:30-17:30 |
Chronic Leukemia Scientific Subcommittee Meeting |
| HALL A |
|
| 15:45-17:15 |
Myeloma - I
Chairs: Jean Luc Harousseau, Meral Beksaç
Myeloma Biology and Molecular Pathology
Mohamad Mohty, France
Bone Diseases and Treatment
Orhan Sezer, Germany
Relapse and Refractory Myeloma
Jean Luc Harousseau, France
|
| HALL B |
|
| 15:45-17:15 |
Palliative Care / Supportive Therapies
Chairs: Claudio Viscoli, Hakan Özdoğu
Current Use of Erythropoietins in Hematological Malignancies
Pellegrino Musto, Italy
The Role of Mucositis as a Predisposing Factor to Systemic Infection and Bacteremia
Claudio Viscoli, Italy
Febrile Neutropenia in 2007
Murat Akova, Turkey
|
| HALL A |
|
| 17:15-18:15 |
Interactive Case Discussions
Chair: Zafer Gülbaş
Acute Lymphoblastic Leukemia
Fahir Özkalemkaş, Turkey
Chair: Nejat Akar
Pediatric Acute Lymphoblastic Leukemia
Tiraje Celkan, Turkey
|
| HALL B |
|
| 17:15-18:15 |
Interactive Case Discussions
Chair: Serdar Bedii Omay
Follicular Lymphoma
Berksoy Şahin, Turkey
Chair: Mustafa Çetiner
Multiple Myeloma
Meral Beksaç, Turkey
|
| May 25th, 2007, Friday |
| HALL A |
|
| 09:00-10:30 |
Follicular Lymphoma
Chairs: Anthony Goldstone, Bülent Ündar
Follicular Lymphoma Pathology
Işınsu Kuzu, Turkey
Treatment of Follicular Lymphoma
Eva Kimby, Sweden
Follicular Lymphoma High Dose Therapy
Anthony H. Goldstone, UK |
| 10:30-10:45 |
Break |
| |
SCIENTIFIC SUBCOMMITTEE MEETING |
| 10:00-12:30 |
Acut Leukemia Scientific Subcommittee Meeting |
| HALL A |
|
| 10:45-12:15 |
Agressive Lymphoma
Chairs: Andreas Rosenwald, Semra Paydaş
Agressive Lymphoma Pathology
Andreas Rosenwald, Germany
DLBCL First Line Treatment
Burhan Ferhanoğlu, Turkey
DLBCL Relapse, Resistant Cases and Transplantation
Koen Van Besien, USA |
| 12:15-13:15 |
Lunch |
| HALL B |
|
| 13:15-14:15 |
Satellite Symposia, Roche
New Perspectives in Diffuse Large B Cell Lymphoma
Chair: Burhan Ferhanoğlu, Turkey
Michael Pfreundschuh, Germany |
| 14:15-14:30 |
Break |
| HALL A |
|
| 14:30-16:00 |
Hodgkin’s Disease
Chairs: Andreas Josting, Nilgün Sayınalp
Hodgkin’s Diseases First Line Treatment
Volker Diehl, Germany
Relapse and Refractory Hodgkin’s Diseases
Andreas Josting, Germany |
| 16:00-16:15 |
Break |
| HALL A |
|
| 16:15-17:15 |
Myeloproliferative Disorders
Chairs: Yücel Tangün, Rauf Haznedar
Biology Diagnosis and Clasification of MPD
Johannes Jacobus Michiels, Belgium
The Targets of Therapy in Polycythemia Vera and Thrombocythemia
Tiziano Barbui, Italy
|
| HALL A |
|
| 17:15-18:15 |
Interactive Case Discussions
Chair: Ayşen Timurağaoğlu
Chronic Myeloid Leukemia
İbrahim Haznedaroğlu, Turkey
Nilgün Sayınalp, Turkey
Chair: Mehmet Ali Özcan
Chronic Lymphocytic Leukemia
Bülent Ündar, Turkey |
| HALL B |
|
| 17:15-18:15 |
Interactive Case Discussions
Chair: Tanju Atamer
Mantle Cell Lymphoma
Gülsan Sucak Türköz, Turkey
Chair: Önder Arslan
DLBCL
Mustafa Çetin, Turkey |
| May 26th, 2007, Saturday |
| HALL A |
|
| 09:00-10:30 |
Chronic Myeloid Leukemia
Chairs: Jane Apperley, İbrahim Haznedaroğlu
CML: Case Closed?
Junia V. Melo, UK
Stem Cell Transplantation in CML
Jane Apperley, UK
Hype or Hope; Novel Tyrosine Kinease Inhibitors
Justus Duyster, Germany |
| SCIENTIFIC SUBCOMMITTEE MEETING |
| 10:00-12:30 |
Lymphoma Scientific Subcommittee Meeting |
| 10:30-10:45 |
Break |
| HALL A |
|
| 10:45-12:15 |
Myelodysplastic Syndrome
Chairs: Tiziano Barbui, Zafer Gülbaş
The Molecular Pathogenesis of MDS
Thomas Look, USA
Current Non Transplant Treatment Strategies in MDS
Azra Raza, USA
The Role of Allogeneic Stem Cell Transplantation in MDS
Theo de Witte, The Netherlands |
| 12:15-13:15 |
Lunch |
| HALL B |
|
| 13:15-14:15 |
Satellite Symposia, Novartis
Optimal Bisphosphonate Treatment in Multiple Myeloma |
| 14:15-14:30 |
Break |
| HALL B |
|
| 14:30-15:30 |
Satellite Symposia, Erkim
Current Status of Thalidomide in the Treatment of Multiple Myeloma
Chair: Levent Ündar, Turkey
Thalidomide Treatment in Relapsed, Refractory Multiple Myeloma
Mario Boccadoro, Italy
Recent Advances of Thalidomide in the Treatment of Multiple Myeloma
Jean Luc Harousseau, France |
| 15:30-15:45 |
Break |
| HALL A |
|
| 15:45-17:15 |
Chronic Lymphocytic Leukemia
Chairs: Sante Tura, Muhit Özcan
Practical Guidelines of the Therapy of CLL
Sante Tura, Italy
Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for LLM: Hype, Reality or Time for a Rethink?
Arnon Nagler, Israel
Current Management of Hairy Cell Leukemia
Tadeusz Robak, Poland |
| HALL B |
|
| 15:45-17:15 |
Myeloma - II
Chairs: Orhan Sezer, Levent Ündar
First Line Treatment of Multiple Myeloma
Guido Tricot, USA
Stem Cell Transplantation in Multiple Myeloma The German Experience
Herman Einsele, Germany
|
| |
Contents - Abstracts |
